Addressing challenges in biomarker translation from a clinical perspective

Brian Rappold will give a lecture in the GPMLS lecture series titled Addressing challenges in biomarker translation from a clinical perspective.

Brian Rappold is the R&D Director for Labcorp in the Research Triangle Park, North Carolina. He has served as the clinical chemistry chair for the American Society for Mass Spectrometry as well as on the scientific committees for endocrinology and small molecule analysis/toxicology for Mass Spectrometry: Applications to the Clinical Laboratory (MSACL).

Rappold has published scientific articles and presented his research at international conventions on topics including hydrophilic interaction liquid chromatography for bio-analysis, multiplexed mass spectrometric detection of amino acidopathies, and the origins and solutions of ion suppression in electrospray ionization.

Brian is a recognized expert in the field of method development and validation of mass spectrometry assays for clinical diagnostic use, teaching courses on the topic at numerous scientific conferences.   Brian also co-authored the chapter “Development and Validation of Small Molecule Analytes By Liquid Chromatography-Tandem Mass Spectrometry” in the last 3 editions of the Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. He is the current vice chair of the document committee for C62-A3, the best practice guidelines for liquid chromatography mass spectrometry in clinical analysis.